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Allospecificity of Liver Allograft-Derived Lymphocytes 
and Correlation With Clinicopathologic Findings 
B.H. Markus, A.J. Demetris, J.J. Fung, S. Saidman, A. Zeevl, T.E. Starzl, and R.J. Duquesnoy 
PREVIOUS studies have shown that acti-
vated T cells can be propagated in vitro 
from liver allograft biopsies in presence of 
exogenous recombinant IL 2. Further analysis 
of these biopsy-grown lymphocytes has 
revea led the presence of alloreactive T cells 
specific for donor HLA antigens. Often 
enough, these cell cultures exhibit restricted 
specificity patterns against one or few of the 
donor HLA antigens. This alloreactivity could 
also be blocked with monoclonal antibodies 
(MoAb) against appropriate HLA determi-
nants,u Similar observations have also been 
made on lymphocyte cultures grown from 
heart transplant biopsies. In certain patients, 
there appeared a sequential infiltration of the 
allograft by class I-specific lymphocytes in 
earlier biopsies followed by class II- or mixed 
class l/ll-specific lymphocytes in later biop-
sies. 3 
The aim of this study was to evaluate the 
association of the HLA class I and class II 
allospecificity of lymphocytes grown from 
liver allograft biopsies with clinical, biochemi-
cal, and histopathologic findings. 
MATERIALS AND METHODS 
All liver transplant recipients received cyclosporine 
and steroids as immunosuppressive drugs. As of Decem-
ber 1984. OKT3 MoAb therapy had been added to treat 
acute rejection episodes. Samples of hepatic allografts 
were obtained from percutaneous liver biopsies. intra-
operative liver biopsies, or removed allografts. Indications 
for sampling were derangements in liver function tests 
and bile composition. All samples were taken in a sterile 
manner for propagation of infiltrating cells and histologic 
evaluation. Liver biopsies were divided into smaller seg-
ments and cultured with recombinant IL 2. The cultured 
lymphocytes were tested against cryopreserved donor 
splenocytes, exogenous IL 2, and an informative panel of 
unrelated lymphocytes with known HLA type. In block-
ing studies. different anti-class I and anti-class" MoAbs 
were tested for their inhibitory effect on the PL T response 
of these cultured T cells. i 
Information about the clinical and biochemical data 
prior to taking a biopsy was obtained from the medical 
charts with special attention to the time interval after the 
liver transplant procedure, bilirubin total and direct 
(TOT BI L. DIR BIL). serum glutamate oxalocetic trans-
aminase (SGOT). serum glutamate pyruvate transami-
nase (SGPT), alkaline phosphatase (AP), and gamma 
glutamyl transpeptidase (GGTP). All values were 
recorded from the day prior to obtaining the biopsies. 
All liver tissue submitted for histopathologic review 
was taken from the same biopsy core or from the same 
region of the liver (in failed allografts) as samples used for 
lymphocyte cultures. The tissues were fixed in neutral 
buffered formalin. sectioned at 6 /Lm and routinely 
stained with hematoxylin, eosin, and trichrome stains. 
Histologic sections were examined in a blind manner by 
one of the authors (A.J. Demetris). Each biopsy and/or 
resection specimen was reviewed according to a defined 
protocol with special emphasis on the presence of a 
mononuclear portal inflammatory infiltrate associated 
with ductal epithelial and venular endothelial damage"'· 
Sta tistical analysis of relevant data was performed by 
the non parametric statistical tests of Mann-Whitney and 
Kruskal-Wallis using the SPSSPC software package. 7 
RESULTS 
For 25 of 49 lymphocyte cultures estab-
lished from liver allograft biopsies, we could 
determine the specificity towards HLA class I 
Cn = 6), mixed HLA class I and II Cn = 9), or 
HLA class II antigens (n = 10). The median 
of the interval from transplant to biopsy date 
was eight days (range from four to 18) for 
HLA class 1, 13 days (range from two to 75) 
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for HLA class Illl, and 31 days (range from 
five to 753) for HLA class II-specific T cell 
cultures (statisticaUy significant between 
class I and class II, P = .039). There was no 
statistically significant difference observed in 
the bilirubin, SGOT, and SGPT values for the 
different groups, although a trend towards 
higher values for biopsies exhibiting class II-
specific T cells was noted. In contrast we 
observed a statistically significant elevation of 
GGTP and AP values associated with the 
appearance of HLA class II-specific cells in 
the biopsy-derived lymphocyte cultures (class 
I v class II, for GGTP P = .017, for AP 
P = .030; class I v combined class Jill + II, 
for GGTP P = .022, for AP P = .011) (Fig 1 
left and right). 
Histopathologic examination of tissues 
from which HLA class I only specific cells 
were expanded showed mild to severe portal 
tract inflammation consisting of an admixture 
of cells typical of that described for acute 
cellular rejection. 5.6 The percentage of biliary 
ducts damaged was equal to or less than 60% 
in all cases. 
In general, biopsies from specimens with an 
HLA class II specificity only showed a mild to 
moderate portal tract infiltrate. In no instance 
was the portal inflammation scored as "se-
vere." Two biopsies of liver aUografts from 
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which lymphocyte cultures expressed only 
HLA class II specificity were obtained during 
the first week posttransplant. Both were diag-
nosed as having harvesting injury. Rejection 
was not thought to be the primary cause of 
graft dysfunction in these instances, even 
though the lymphocytes expanded in culture 
showed donor-specific reactivity. Additional-
ly, the markedly elevated cytosolic hepatocel-
lular enzymes from both of these patients at 
the time of biopsy were supportive of this 
contention.6 The other allograft biopsy speci-
mens (greater than 1 week posttransplant) 
from which lymphocyte cultures showed class 
II only reactivity, showed a mild (n = 4) or 
moderate (n = 4) portal infiltrate. Bile duct 
damage was higher than in both other groups. 
Subsequent biopsy samples from three of 
these eight patients continued to show an 
indolent, ongoing chronic rejection process 
with prominent duct damage. In fact, two of 
these grafts were later lost because of a 
paucity of bile ducts and obliterative 
vasculopa thy. 
Biopsies in which there were both HLA 
class I and II reactivity displayed histopatho-
logic findings intermittent between the two 
groups. The diagnoses varied from preserva-
tion injury to severe rejection. Notably, one of 
the patients with both class I and II donor-
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Fig 1. GGTP Heft) and AP (right) values and median for each group of HLA specificities. A statistically significant 
elevation of GGTP and AP values associated with the appearance of HLA class II-specific cells in the biopsy-derived 
lymphocytel:ulwi80 was noted. (Class I v class II, for GGTP P.017. for AP p~ .030; class I v combined class lill ~ II. 
for GGTP P -- _022. tor AP. P ~ 0.11.1 
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LIVER ALLOGRAFT DERIVED LYMPHOCYTES 
specific reactivi ty experienced progressive 
graft dysfunction resulting in graft loss from 
chronic rejection. 
DICSUSSION 
Previous studies have shown that biopsy-
grown lymphocytes from certain heart allo-
grafts exhibited a trend towards HLA class 
I-specific cells being more predominant in 
earlier biopsies, followed by mixed HLA class 
I I IJ- or class If -specific cells in later biopsies. 3 
The same trend has been noted here in lym-
phocytes grown from liver allografts. The 
infiltration with class II-specific cells was 
associated with a rise in GGTP and AP values 
as indicated by the statistically significant 
elevation of mean GGTP and AP in these 
groups. GGTP is specifically released at times 
of biliary epithelial cell (BEC) damage. In 
addition, BECs are the main structural ele-
ment capable of expressing HLA class II 
antigens in the liver allograft and are a prefer-
ential target for invading lymphocytes.8 
Therefore it seems possible that the main 
effector cell in the rejection cascade attacking 
the BECs are class II-specific lymphocytes. 
Class I-specific lymphocytes might playa 
role in inducing the primary steps of the 
rejection cascade. On vascular endothelial 
cells class I antigens rather than class II are 
present early after transplantation. These 
class I antigens can serve as specific recogni-
tion structures for class I-specific lympho-
cytes, thereby facilitating the preferential 
adherence of class I-specific lymphocytes to 
vascular endothelium and their subsequent 
migration into the surrounding tissues. 9. ,o 
Through the release of lymphokines, specif-
ically 'Y- IFN, these invading class I specific 
lymphocytes can promote additional HLA 
class II antigen expression on the vascular 
endothelial cells I J with subsequent class II-
specific lymphocyte adherence and invasion. 'o 
In addition, various other causes such as 
ischemia and viral infections might serve as 
class II antigen promotors on VEC and BEC, 
thereby facilitating class II-specific infiltrates 
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and promoting class II-specific intragraft 
effector mechanisms. Interestingly, harvest-
ing injury was determined to be the major 
cause of liver dysfunction in both cases in 
which biopsies were taken during the first 
week after transplantation and the subsequent 
lymphocyte culture displayed HLA class II 
specificity. 
Immunocytochemical analysis has previ-
ously shown a selective destruction of bile 
ducts in liver allografts undergoing rejection 
as demonstrated by striking elevations of 
GGTP activity.8 It was postulated that the 
induced expression of DR/la antigens on 
structures targeted for immune destruction 
may be an important event in the pathogenesis 
of liver allograft rejection. The current analy-
sis suggests that the increased destruction of 
bile duct epithelium might be associated with 
HLA class II-specific lymphocytes invading 
the allograft tissue, and that this damage 
might be selectively restricted to HLA class 
II-bearing target structures, namely the bil-
iary epithelium. Class I-specific T cells could 
thereby function as a promotor for class II-
specific lymphocyte invasion. This could 
finally lead to recognition of class II antigens 
on BEC and subsequent damage to BEC as 
shown by elevated serum levels of GGTP and 
AP in times of a class II-specific T cell 
infiltrate. 
The histopathologic findings described in 
this report, although limited in number, offer 
some interesting avenues for further investi-
gation. It has been postulated that the ideal 
situation for the development of chronic rejec-
tion or loss of bile ducts is partial or complete 
matching at the class II locus with a complete 
disparity at the class I region. '2 The findings 
reported here, however, suggest the possibility 
that some of the duct damage observed in this 
syndrome may be the result of class II antigen 
disparity between the donor and recipient. 
However, further evaluation is needed in 
terms of defining the type of donor specificity 
(ie, proliferative v cytotoxic response), the 
addition of greater numbers to confirm these 
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observations, and the sequential culturing, of 
samples from the same patient. 
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